Campaign details
Brand: Pfizer Canada Inc.Agency: NATIONAL Public Relations
The assignment
Pfizer Canada Inc., a biopharmaceutical company, engaged national to generate public awareness about mBC and build on important relationships with the breast cancer community, including patient groups, caregivers, healthcare professionals, and Canadians with a direct connection to the disease. After a very successful inaugural campaign in 2016, we were tasked with refining and executing the second year of the multi-channel program It's About mBCTime in 2017.
Pfizer's IBRANCE (palbociclib) is a prescription medicine for ER+/HER2 – metastatic breast cancer in post-menopausal women. As of January 2018,...